Respiratory Standard & Sleep Apnea — 391.41(b)(5)

The Regulatory Text — 391.41(b)(5)

49 CFR 391.41(b)(5) requires that a driver:

"Has no established medical history or clinical diagnosis of a respiratory dysfunction likely to interfere with his/her ability to control and drive a commercial motor vehicle safely."

Like the cardiovascular standard, this is written as a functional test — the question is not whether a respiratory diagnosis exists, but whether it is likely to interfere with safe driving. A driver with well-controlled mild asthma who has no history of a driving-relevant exacerbation is a very different case from a driver with severe, poorly controlled COPD causing frequent dyspnea. When a medical examiner detects a respiratory dysfunction that in any way appears likely to interfere with safe control of a CMV, the driver must be referred to a specialist for further evaluation and therapy before a certification decision is finalized.

Conditions commonly evaluated under (b)(5)

Spirometry, arterial blood gas testing, or chest imaging may be ordered when history or exam findings raise concern, feeding into the same referral-and-documentation pattern used for cardiovascular disease: identify the risk, refer if indicated, and base the certification interval on specialist input. Restrictive lung diseases such as pulmonary fibrosis, and neuromuscular conditions that weaken the diaphragm, are evaluated the same way even though they are less common than COPD or asthma in the driver population — the examiner's job is not to diagnose these conditions from scratch, but to recognize when a reported history, an abnormal respiratory rate or pattern, or an observed exertional symptom during the exam warrants specialist referral rather than an on-the-spot certification decision.

Obstructive Sleep Apnea: No Single Mandatory Threshold

OSA deserves separate attention because it is a frequent real-world reason for restricted or denied certification, and because the exam likes to test what FMCSA does not require as much as what it does. The Federal Motor Carrier Safety Regulations do not mandate that medical examiners screen every driver for OSA using a specific instrument, and they do not set one universal BMI or Apnea-Hypopnea Index (AHI) cutoff that automatically disqualifies a driver. The 2024 Medical Examiner's Handbook instead directs examiners to weigh a combination of risk factors identified through the driver's health-history responses and the physical exam, including:

• History of a small or crowded airway
• Loud snoring or witnessed apneas reported by a bed partner
• Self-reported excessive sleepiness during major wake periods
• Obesity or a high body mass index (BMI)
• Large neck circumference — commonly recognized around 17 inches or greater in men and 15.5 inches or greater in women
• Hypertension, cardiovascular disease, or a history of stroke or diabetes

No single factor on that list is automatically disqualifying; the examiner uses the overall clinical picture to decide whether referral for a sleep study is warranted.

AHI severity classification

When a sleep study is performed, the resulting Apnea-Hypopnea Index (AHI) is classified using the standard clinical scale:

CPAP compliance criteria

For a driver diagnosed with OSA and treated with continuous positive airway pressure (CPAP), certification generally depends on documented treatment compliance, assessed against all of the following together — meeting some but not all of them is not sufficient:

1. CPAP used for at least 4 hours per night.
2. Used on at least 70% of nights during the monitored period (commonly 30 or 90 days).
3. Residual AHI below 5 events per hour on therapy.
4. Mask leak under 24 L/min.

A driver who meets the hours-per-night and residual-AHI targets but only uses the device on, say, 50% of nights has not demonstrated compliance, because all four criteria must be satisfied together, not any one in isolation. FMCSA leaves the choice of treatment modality — CPAP, weight loss, dental appliance, or a combination — to the treating clinician and driver; the regulations do not mandate CPAP specifically as the only acceptable therapy, only that whatever therapy is used be shown to be effective and consistently followed.

Typical certification progression for treated OSA

Outside of any single mandated rule, common examiner practice for a newly diagnosed, newly treated driver follows a step-up pattern: an initial short conditional certificate (often around 1 month) to confirm the driver has actually started therapy, a follow-up certificate (often around 3 months) once early compliance data is reviewed, and a certificate of up to 1 year once compliance has been consistently documented against the four criteria above. Regardless of how long a driver has been stable on therapy, drivers with a diagnosis of OSA are generally expected to be recertified at least annually, since ongoing compliance — not just the original diagnosis and treatment start — is what keeps the driver safely qualified under (b)(5).